Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fmed.2026.1769131.s001BackgroundThis study examines the connection between the substantial reduction in intrinsic capacity (IC) and unfavorable outcomes across a number of IC subdomains among older adults living in Chinese communities and the use of aspirin, both alone and in combination with angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (ACEI or ARBs).MethodsA 1:1 closest-neighbor propensity score matching (PSM) strategy was used to reduce baseline confounding factors across aspirin users and non-users using cross-sectional data from the Lianyungang ICOPE pilot trial. Multivariate logistic regression analysis was used to evaluate the relationship between aspirin use and a significant deterioration in IC as well as unfavorable outcomes in several IC subdomains (sensory, physical, neuropsychiatric, and nutritional function).ResultsA total of 250 participants were analyzed after propensity score matching. The likelihood of a severe loss of intrinsic capacity was not substantially correlated with aspirin use alone (adjusted odds ratio [OR] = 1.54, 95% confidence interval [CI]: 0.88–2.71, p = 0.134). However, aspirin use was strongly linked to negative outcomes in sensory function, including very poor vision (adjusted OR = 2.95, 95% CI: 1.10–7.94, p = 0.032), poor hearing (adjusted OR = 3.21, 95% CI: 1.29–7.97, p = 0.012), and very poor hearing (adjusted OR = 2.08, 95% CI: 1.02–4.24, p = 0.045), all of which were statistically significant (p ConclusionAspirin use was not significantly correlated with negative outcomes in the categories of nutritional function, neuropsychiatry, or physical health. The incidence of severe loss of intrinsic ability was significantly reduced when aspirin was used in conjunction with angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) (p
Keyword(s):
angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (ACEI or ARBs); aspirin; Foetal Development and Medicine; intrinsic capacity (IC); older adults.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)